331
Views
32
CrossRef citations to date
0
Altmetric
Original Articles

Oral Administration of an Immunostimulatory DNA Sequence from Bifidobacterium longum Improves Th1/Th2 Balance in a Murine Model

, , , , , & show all
Pages 2013-2017 | Received 10 May 2006, Accepted 24 Jun 2006, Published online: 22 May 2014

  • 1) Fuller, R., Probiotics in man and animals. J. Appl. Bacteriol., 66, 365–378 (1989).
  • 2) Matsuzaki, T., Yamazaki, R., Hashimoto, S., and Yokokura, T., The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice. J. Dairy Sci., 81, 48–53 (1998).
  • 3) Ishida, Y., Bandou, I., Kanzato, H., and Yamamoto, N., Decrease in ovalbumin specific IgE of mice serum after oral uptake of lactic acid bacteria. Biosci. Biotechnol. Biochem., 67, 951–957 (2003).
  • 4) Fujiwara, D., Inoue, S., Wakabayashi, H., and Fujii, T., The anti-allergic effects of lactic acid bacteria are strain dependent and mediated by effects on both Th1/Th2 cytokine expression and balance. Int. Arch. Allergy Immunol., 135, 205–215 (2004).
  • 5) Ohno, H., Tsunemine, S., Isa, Y., Shimakawa, M., and Yamamura, H., Oral administration of Bifidobacterium bifidum G9-1 suppresses total and antigen specific immunoglobulin E production in mice. Biol. Pharm. Bull., 28, 1462–1466 (2005).
  • 6) Xiao, J. Z., Kondo, S., Yanagisawa, N., Takahashi, N., Odamaki, T., Iwabuchi, N., Iwatsuki, K., Kokubo, S., Togashi, H., Enomoto, K., and Enomoto, T., Effect of probiotic Bifidobacterium longum BB536 in relieving clinical symptoms and modulating plasma cytokine levels of Japanese cedar pollinosis during the pollen season. A randomized double-blind, placebo-controlled trial. J. Invest. Allergol. Clin. Immunol., 16, 86–93 (2006).
  • 7) Matsuguchi, T., Takagi, A., Matsuzaki, T., Nagaoka, M., Ishikawa, K., Yokokura, T., and Yoshikai, Y., Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through Toll-like receptor 2. Clin. Diagn. Lab. Immunol., 10, 259–266 (2003).
  • 8) Pena, J. A., and Versalovic, J., Lactobacillus rhamnosus GG decreases TNF-alpha production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism. Cell. Microbiol., 5, 277–285 (2003).
  • 9) Krieg, A. M., Yi, A. K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., and Klinman, D. M., CpG motifs in bacterial DNA trigger direct B-cell activation. Nature, 374, 546–549 (1995).
  • 10) Kitazawa, H., Ueha, S., Itoh, S., Watanabe, H., Konno, K., Kawai, Y., Saito, T., Itoh, T., and Yamaguchi, T., AT oligonucleotides inducing B lymphocyte activation exist in probiotic Lactobacillus gasseri. Int. J. Food Microbiol., 65, 149–162 (2001).
  • 11) Kitazawa, H., Watanabe, H., Shimosato, T., Kawai, Y., Itoh, T., and Saito, T., Immunostimulatory oligonucleotide, CpG-like motif exists in Lactobacillus delbrueckii ssp. bulgaricus NIAI B6. Int. J. Food Microbiol., 85, 11–21 (2003).
  • 12) Shimosato, T., Kitazawa, H., Tohno, M., Katoh, S., Kawai, Y., and Saito, T., Development of immune assay system for both CpG and non-CpG DNA from lactic acid bacteria using a transfectant of swine Toll-like receptor 9. Anim. Sci. J., 75, 377–382 (2004).
  • 13) Iliev, I. D., Kitazawa, H., Shimosato, T., Katoh, S., Morita, H., He, F., Hosoda, M., and Saito, T., Strong immunostimulation in murine immune cells by Lactobacillus rhamnosus GG DNA containing novel oligodeoxynucleotide pattern. Cell. Microbiol., 7, 403–414 (2005).
  • 14) Shimosato, T., Kimura, T., Tohno, M., Iliev, I. D., Katoh, S., Ito, Y., Kawai, Y., Sasaki, T., Saito, T., and Kitazawa, H., Strong immunostimulatory activity of AT-oligodeoxynucleotide requires a six-base loop with a self-stabilized 5′-C…G-3′ stem structure. Cell. Microbiol., 8, 485–495 (2006).
  • 15) Takahashi, N., Kitazawa, H., Shimosato, T., Iwabuchi, N., Xiao, J. Z., Iwatsuki, K., Kokubo, S., and Saito, T., An immunostimulatory DNA sequence from a probiotic strain of Bifidobacterium longum inhibits IgE production in vitro. FEMS Immunol. Med. Microbiol., 46, 461–469 (2006).
  • 16) Hemmi, H., Takeuchi, O., Kawai, T., Kaisyo, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., and Akira, S., A toll-like receptor recognized bacterial DNA. Nature, 408, 740–745 (2000).
  • 17) Klinman, D. M., Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat. Rev. Immunol., 4, 249–258 (2004).
  • 18) Takahashi, N., Kitazawa, H., Iwabuchi, N., Xiao, J. Z., Miyaji, K., Iwatsuki, K., and Saito, T., Immunostimulatory oligodeoxynucleotide from Bifidobacterium longum suppresses Th2 immune responses in a murine model. Clin. Exp. Immunol., 145, 130–138 (2006).
  • 19) Nakao, A., Kasai, M., Kumano, K., Nakajima, H., Kurasawa, K., and Iwamoto, I., High-dose oral tolerance prevents antigen-induced eosinophil recruitment into the mouse airways. Int. Immunol., 10, 387–394 (1998).
  • 20) Kitagaki, K., Businga, T. R., and Kline, J. N., Oral administration of CpG-ODNs suppresses antigen-induced asthma in mice. Clin. Exp. Immunol., 143, 249–259 (2006).
  • 21) Yi, A. K., Klinman, D. M., Martin, T. L., Matson, S., and Krieg, A. M., Rapid immune activation by CpG motifs in bacterial DNA. J. Immunol., 157, 5394–5402 (1996).
  • 22) Hartmann, G., Weeratna, R. D., Ballas, A. K., Payette, P., Blackwell, S., Suparto, I., Rasmussen, W. L., Waldschmidt, M., Sajuthi, D., Purcell, R. H., Davis, H. L., and Krieg, A. M., Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune response in vitro and in vivo. J. Immunol., 164, 1619–1624 (2000).
  • 23) Shimosato, T., Tohno, M., Kitazawa, H., Katoh, S., Watanabe, K., Kawai, Y., Aso, H., Yamaguchi, T., and Saito, T., Toll-like receptor 9 is expressed on follicle-associated epithelia containing M cells in swine Peyer’s patches. Immunol. Lett., 98, 83–89 (2005).
  • 24) Otte, J. M., Cario, E., and Podolsky, D. K., Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology, 126, 1054–1070 (2004).
  • 25) Watson, J. L., and McKay, D. M., The immunophysiological impact of bacterial CpG DNA on the gut. Clin. Chim. Acta, 364, 1–11 (2006).
  • 26) Rachmilewitz, D., Katakura, K., Karmeli, F., Hayashi, T., Reinus, C., Rudensky, B., Akira, S., Takeda, K., Lee, J., Takabayashi, K., and Raz, E., Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotic in murine experimental colitis. Gastroenterology, 126, 520–528 (2004).
  • 27) Jijon, H., Backer, J., Diaz, H., Yeung, H., Thiel, D., Mckaigney, C., Simone, C. D., and Madsen, K., DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology, 126, 1358–1373 (2004).
  • 28) Pessi, T., Sutas, Y., Hurme, M., and Isolauri, E., Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin. Exp. Allergy, 30, 1804–1808 (2000).
  • 29) Kalliomäki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P., and Isolauri, E., Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet, 357, 1076–1079 (2001).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.